海西新药将延迟上市
HAIXI PHARMAHAIXI PHARMA(HK:02637) Zhi Tong Cai Jing·2025-10-16 13:36

Core Viewpoint - The company, HaiXi New Drug (02637), has announced a delay in its listing schedule due to the need for additional time to finalize the distribution results announcement and obtain regulatory approval [1] Group 1 - The company is working to provide the market with the latest information as soon as feasible [1]